All Stories

  1. Evaluation of Active Brown Adipose Tissue by the Use of Hyperpolarized [1-13C]Pyruvate MRI in Mice
  2. Insulin inhibits autophagy signaling independent of counter-regulatory hormone levels, but does not affect the effects of exercise
  3. Metformin targets brown adipose tissue in vivo and reduces oxygen consumption in vitro
  4. Long-Term High-Dose Resveratrol Supplementation Reduces Bone Mass and Fracture Strength in Rats
  5. Characterization of immortalized human brown and white pre-adipocyte cell models from a single donor
  6. Reduction in serum fibroblast growth factor-21 after gastric bypass is related to changes in hepatic fat content
  7. Regulation of glycolysis in brown adipocytes by HIF-1α
  8. Inflammation Downregulates UCP1 Expression in Brown Adipocytes Potentially via SIRT1 and DBC1 Interaction
  9. Comprehensive Metabolomic Analysis in Blood, Urine, Fat, and Muscle in Men with Metabolic Syndrome: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Resveratrol after Four Months’ Treatment
  10. Expression Patterns and Correlations with Metabolic Markers of Zinc Transporters ZIP14 and ZNT1 in Obesity and Polycystic Ovary Syndrome
  11. High expression of organic cation transporter 3 in human BAT-like adipocytes. Implications for extraneuronal norepinephrine uptake
  12. No Beneficial Effects of Resveratrol on the Metabolic Syndrome: A Randomized Placebo-Controlled Clinical Trial
  13. Substrate Metabolism and Insulin Sensitivity During Fasting in Obese Human Subjects: Impact of GH Blockade
  14. Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls
  15. Effects of insulin-induced hypoglycaemia on lipolysis rate, lipid oxidation and adipose tissue signalling in human volunteers: a randomised clinical study
  16. Growth Hormone and Insulin Signaling in Acromegaly: Impact of Surgery Versus Somatostatin Analog Treatment
  17. Erythropoietin does not activate erythropoietin receptor signaling or lipolytic pathways in human subcutaneous white adipose tissue in vivo
  18. Regulation of Lipolysis and Adipose Tissue Signaling during Acute Endotoxin-Induced Inflammation: A Human Randomized Crossover Trial
  19. Vitamin K2 (menaquinone-7) prevents age-related deterioration of trabecular bone microarchitecture at the tibia in postmenopausal women
  20. PAPP-A, IGFBP-4 and IGF-II are secreted by human adipose tissue cultures in a depot-specific manner
  21. Stress hormone release is a key component of the metabolic response to lipopolysaccharide: studies in hypopituitary and healthy subjects
  22. SILAC-MS Based Characterization of LPS and Resveratrol Induced Changes in Adipocyte Proteomics – Resveratrol as Ameliorating Factor on LPS Induced Changes
  23. Differential regulation of lipid and protein metabolism in obese vs. lean subjects before and after a 72-h fast
  24. Impaired Insulin Suppression of VLDL-Triglyceride Kinetics in Nonalcoholic Fatty Liver Disease
  25. Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction
  26. Resveratrol Increases Osteoblast Differentiation In Vitro Independently of Inflammation
  27. Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment
  28. Combined Insulin Deficiency and Endotoxin Exposure Stimulate Lipid Mobilization and Alter Adipose Tissue Signaling in an Experimental Model of Ketoacidosis in Subjects With Type 1 Diabetes: A Randomized Controlled Crossover Trial
  29. Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
  30. Continuous Glucose Monitoring After Gastric Bypass to Evaluate the Glucose Variability After a Low-Carbohydrate Diet and to Determine Hypoglycemia
  31. LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol
  32. Gene expression of the zinc transporter ZIP14 (SLC39a14) is affected by weight loss and metabolic status and associates with PPARγ in human adipose tissue and 3T3-L1 pre-adipocytes
  33. Melanocortin agonists stimulate lipolysis in human adipose tissue explants but not in adipocytes
  34. Reduced fat mass and increased lean mass in response to 1 year of melatonin treatment in postmenopausal women: A randomized placebo-controlled trial
  35. Causes of Vitamin D Deficiency and Effect of Vitamin D Supplementation on Metabolic Complications in Obesity: a Review
  36. The Effect of Treatment With PTH on Undercarboxylated Osteocalcin and Energy Metabolism in Hypoparathyroidism
  37. Resveratrol and inflammation: Challenges in translating pre-clinical findings to improved patient outcomes
  38. GH signaling in human adipose and muscle tissue during ‘feast and famine’: amplification of exercise stimulation following fasting compared to glucose administration
  39. Resveratrol Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice
  40. Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men
  41. Effect of resveratrol on experimental non-alcoholic steatohepatitis
  42. Prolonged erythropoietin treatment does not impact gene expression in human skeletal muscle
  43. Adipose tissue, estradiol levels, and bone health in obese men with metabolic syndrome
  44. Intact Pituitary Function is Decisive for the Catabolic Response to TNF-α: Studies of Protein, Glucose and Fatty Acid Metabolism in Hypopituitary and Healthy Subjects
  45. Chronic adrenergic stimulation induces brown adipose tissue differentiation in visceral adipose tissue
  46. Growth Hormone Signaling in Muscle and Adipose Tissue of Obese Human Subjects: Associations With Measures of Body Composition and Interaction With Resveratrol Treatment
  47. Resveratrol Increases Bone Mineral Density and Bone Alkaline Phosphatase in Obese Men: A Randomized Placebo-Controlled Trial
  48. Intrahepatic fat content correlates with soluble CD163 in relation to weight loss induced by Roux-en-Y gastric bypass
  49. GH signaling in skeletal muscle and adipose tissue in healthy human subjects: impact of gender and age
  50. Regulation of CD163 mRNA and soluble CD163 protein in human adipose tissue in vitro
  51. Kinetics and utilization of lipid sources during acute exercise and acipimox
  52. Acute and Short-term Chronic Testosterone Fluctuation Effects on Glucose Homeostasis, Insulin Sensitivity, and Adiponectin: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
  53. Acute effects of monounsaturated fat on postprandial lipemia and gene expression in first-degree relatives of subjects with type 2 diabetes
  54. Effects of LPS and dietary free fatty acids on MCP-1 in 3T3-L1 adipocytes and macrophages in vitro
  55. Inhibitory effects of resveratrol on hypoxia-induced inflammation in 3T3-L1 adipocytes and macrophages
  56. Short-term resveratrol supplementation stimulates serum levels of bone-specific alkaline phosphatase in obese non-diabetic men
  57. Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease
  58. Human Adipose Tissue Macrophages Are Enhanced but Changed to an Anti-Inflammatory Profile in Obesity
  59. Growth hormone-induced insulin resistance in human subjects involves reduced pyruvate dehydrogenase activity
  60. Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels — Results from a randomized trial
  61. Whole body metabolic effects of prolonged endurance training in combination with erythropoietin treatment in humans: a randomized placebo controlled trial
  62. Direct Effects of TNF-  on Local Fuel Metabolism and Cytokine Levels in the Placebo-Controlled, Bilaterally Infused Human Leg: Increased Insulin Sensitivity, Increased Net Protein Breakdown, and Increased IL-6 Release
  63. The Macrophage‐Specific Serum Marker, Soluble CD163, Is Increased in Obesity and Reduced After Dietary‐Induced Weight Loss
  64. Effects of a meal rich in medium-chain saturated fat on postprandial lipemia in relatives of type 2 diabetics
  65. Resveratrol in metabolic health: an overview of the current evidence and perspectives
  66. Resveratrol has inhibitory effects on the hypoxia-induced inflammation and angiogenesis in human adipose tissue in vitro
  67. Direct Effects of Locally Administered Lipopolysaccharide on Glucose, Lipid, and Protein Metabolism in the Placebo-Controlled, Bilaterally Infused Human Leg
  68. Gene expression in skeletal muscle after an acute intravenous GH bolus in human subjects: identification of a mechanism regulating ANGPTL4
  69. The Effect of High-Dose Vitamin D Supplementation on Calciotropic Hormones and Bone Mineral Density in Obese Subjects with Low Levels of Circulating 25-Hydroxyvitamin D: Results from a Randomized Controlled Study
  70. Independent Effects of Testosterone on Lipid Oxidation and VLDL-TG Production
  71. Ghrelin- and GH-induced insulin resistance: no association with retinol-binding protein-4
  72. Effect of weight loss and exercise on angiogenic factors in the circulation and in adipose tissue in obese subjects
  73. Acute exercise increases circulating inflammatory markers in overweight and obese compared with lean subjects
  74. Investigations of the Anti-inflammatory Effects of Vitamin D in Adipose Tissue: Results from an In Vitro Study and a Randomized Controlled Trial
  75. The production and regulation of IGF and IGFBPs in human adipose tissue cultures
  76. High-Dose Resveratrol Supplementation in Obese Men: An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition
  77. Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet
  78. Estradiol acutely inhibits whole body lipid oxidation and attenuates lipolysis in subcutaneous adipose tissue: a randomized, placebo-controlled study in postmenopausal women
  79. Expression of vitamin D-metabolizing enzymes in human adipose tissue—the effect of obesity and diet-induced weight loss
  80. Adipose expression of adipocytokines in women with polycystic ovary syndrome
  81. Reduced mRNA and Protein Expression of Perilipin A and G0/G1Switch Gene 2 (G0S2) in Human Adipose Tissue in Poorly Controlled Type 2 Diabetes
  82. Fat Content in Liver and Skeletal Muscle Changes in a Reciprocal Manner in Patients with Acromegaly during Combination Therapy with a Somatostatin Analog and a GH Receptor Antagonist: A Randomized Clinical Trial
  83. Evaluation of Functional Erythropoietin Receptor Status in Skeletal Muscle In Vivo: Acute and Prolonged Studies in Healthy Human Subjects
  84. Satiety scores and satiety hormone response after sucrose-sweetened soft drink compared with isocaloric semi-skimmed milk and with non-caloric soft drink: a controlled trial
  85. Erythropoietin administration acutely stimulates resting energy expenditure in healthy young men
  86. The Effect of Weight Loss on Serum Mannose-Binding Lectin Levels
  87. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study
  88. GLUT4 and UBC9 Protein Expression Is Reduced in Muscle from Type 2 Diabetic Patients with Severe Insulin Resistance
  89. Insulin resistance after a 72-h fast is associated with impaired AS160 phosphorylation and accumulation of lipid and glycogen in human skeletal muscle
  90. Differential effects of dietary protein sources on postprandial low-grade inflammation after a single high fat meal in obese non-diabetic subjects
  91. Growth Hormone (GH)-Induced Insulin Resistance Is Rapidly Reversible: An Experimental Study in GH-Deficient Adults
  92. Fasting, But Not Exercise, Increases Adipose Triglyceride Lipase (ATGL) Protein and Reduces G(0)/G(1) Switch Gene 2 (G0S2) Protein and mRNA Content in Human Adipose Tissue
  93. Acute Peripheral Metabolic Effects of Intraarterial Leg Infusion of Somatostatin in Healthy Young Men
  94. Effect of industrially producedtransfat on markers of systemic inflammation: evidence from a randomized trial in women
  95. The Expression and Regulation of Bone-acting Cytokines in Human Peripheral Adipose Tissue in Organ Culture
  96. Insulin and GH Signaling in Human Skeletal Muscle In Vivo following Exogenous GH Exposure: Impact of an Oral Glucose Load
  97. Rosiglitazone Decreases Bone Mass and Bone Marrow Fat
  98. Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss
  99. Exercise and Fasting Activate Growth Hormone-Dependent Myocellular Signal Transducer and Activator of Transcription-5b Phosphorylation and Insulin-Like Growth Factor-I Messenger Ribonucleic Acid Expression in Humans
  100. Decreased Lipid Intermediate Levels and Lipid Oxidation Rates Despite Normal Lipolysis in Patients with Hypothyroidism
  101. Reduced Expression of Uncoupling Protein 2 in Adipose Tissue in Patients with Hypothyroidism
  102. Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants
  103. Diet-Induced Weight Loss and Exercise Alone and in Combination Enhance the Expression of Adiponectin Receptors in Adipose Tissue and Skeletal Muscle, but Only Diet-Induced Weight Loss Enhanced Circulating Adiponectin
  104. Reduced cannabinoid receptor 1 protein in subcutaneous adipose tissue of obese
  105. Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study
  106. Impact of Growth Hormone Receptor Blockade on Substrate Metabolism during Fasting in Healthy Subjects
  107. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome
  108. Comparable reduction of the visceral adipose tissue depot after a diet-induced weight loss with or without aerobic exercise in obese subjects: a 12-week randomized intervention study
  109. Effects on Food Intake and Blood Lipids of Cannabinoid Receptor 1 Antagonist Treatment in Lean Rats
  110. Peroxisome proliferator-activated receptor gamma agonism modifies the effects of growth hormone on lipolysis and insulin sensitivity
  111. The anti-diabetic AMPK activator AICAR reduces IL-6 and IL-8 in human adipose tissue and skeletal muscle cells
  112. Growth Hormone Signalingin Vivoin Human Muscle and Adipose Tissue: Impact of Insulin, Substrate Background, and Growth Hormone Receptor Blockade
  113. Low Sirt1 expression, which is upregulated by fasting, in human adipose tissue from obese women
  114. Upregulation of Adipose 11-β-Hydroxysteroid Dehydrogenase Type 1 Expression in Ovariectomized Rats Is due to Obesity Rather Than Lack of Estrogen
  115. 11β-HSD Type 1 Expression in Human Adipose Tissue: Impact of Gender, Obesity, and Fat Localization*
  116. Circulating sex hormones and gene expression of subcutaneous adipose tissue oestrogen and alpha-adrenergic receptors in HIV-lipodystrophy: implications for fat distribution
  117. Muscle GLUT4 in cirrhosis
  118. Zinc-transporter genes in human visceral and subcutaneous adipocytes: Lean versus obese
  119. GH receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus
  120. Glucose-stimulated prehepatic insulin secretion is associated with circulating alanine, triglyceride, glucagon, lactate and TNF-alpha in patients with HIV-lipodystrophy
  121. Growth Hormone (GH) Substitution in GH-Deficient Patients Inhibits 11β-Hydroxysteroid Dehydrogenase Type 1 Messenger Ribonucleic Acid Expression in Adipose Tissue
  122. Tumor necrosis factor α is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy
  123. Adiponectin Receptors in Human Adipose Tissue: Effects of Obesity, Weight Loss, and Fat Depots*
  124. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines
  125. Monocyte Chemoattractant Protein-1 Release Is Higher in Visceral than Subcutaneous Human Adipose Tissue (AT): Implication of Macrophages Resident in the AT
  126. Erratum
  127. Adiponectin: action, regulation and association to insulin sensitivity
  128. Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy
  129. Increased adiposity and reduced adipose tissue mRNA expression of uncoupling protein-2 in first-degree relatives of type 2 diabetic patients: evidence for insulin stimulation of UCP-2 and UCP-3 gene expression in adipose tissue
  130. Estrogen has direct effect on adipose tissue metabollism
  131. AICAR stimulates adiponectin and inhibits cytokines in adipose tissue
  132. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects
  133. Subcutaneous Adipocytes Can Differentiate into Bone-Forming Cellsin Vitroandin Vivo
  134. Long term follow up of patients who underwent jejunoileal bypass for morbid obesity
  135. Stimulation of PAI-1 and adipokines by glucose in human adipose tissue in vitro
  136. Anti-glucocorticoid effects of progesterone in vivo on rat adipose tissue metabolism
  137. Survival Following a Metformin Overdose of 63 g: A Case Report
  138. Impact of Dietary FA and Energy Restriction on Plasma Leptin and ob Gene Expression in Mice
  139. Differences in Plasminogen Activator Inhibitor 1 in Subcutaneous Versus Omental Adipose Tissue in Non-Obese and Obese Subjects
  140. Estrogen Reduces Pro-Inflammatory Cytokines in Rodent Adipose Tissue: StudiesIn vivoandIn vitro
  141. Metformin, but not Thiazolidinediones, Inhibits Plasminogen Activator Inhibitor-1 Production in Human Adipose Tissuein Vitro
  142. The Effect of Long-Term Pharmacological Antilipolysis on Substrate Metabolism in Growth Hormone (GH)-Substituted GH-Deficient Adults
  143. Opposite Regulation of Interleukin-8 and Tumor Necrosis Factor-α by Weight Loss
  144. Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro
  145. Differential impact of acute and chronic lipotoxicity on gene expression in INS-1 cells
  146. The Effect of Chronic Exposure to Fatty Acids on Gene Expression in Clonal Insulin-Producing Cells: Studies Using High Density Oligonucleotide Microarray
  147. Regulation of UCP1, UCP2, and UCP3 mRNA Expression in Brown Adipose Tissue, White Adipose Tissue, and Skeletal Muscle in Rats by Estrogen
  148. Demonstration of estrogen receptor subtypes α and β in human adipose tissue: influences of adipose cell differentiation and fat depot localization
  149. Insulin and Contraction Directly Stimulate UCP2 and UCP3 mRNA Expression in Rat Skeletal Muscle in Vitro
  150. Regulation of Interleukin 8 Production and Gene Expression in Human Adipose Tissue in Vitro
  151. Gene Expression of a Truncated and the Full-Length Growth Hormone (GH) Receptor in Subcutaneous Fat and Skeletal Muscle in GH-Deficient Adults: Impact of GH Treatment
  152. Systemic Administration of Epidermal Growth Factor Increases UCP3 mRNA Levels in Skeletal Muscle and Adipose Tissue in Rats
  153. Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients
  154. Epidermal growth factor and insulin-like growth factor I upregulate the expression of the epidermal growth factor system in rat liver
  155. Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women
  156. Differential expression of prostaglandin receptor mRNAs during adipose cell differentiation
  157. Regulation of Leptin by Steroid Hormones in Rat Adipose Tissue
  158. Systemic Administration of Epidermal Growth Factor Reduces Fat Mass in Rats: Effects on the Hormone-Sensitive-Lipase, Lipoprotein Lipase and Leptin
  159. Effects of long-term total fasting and insulin on ob gene expression in obese patients
  160. Expression of the two isoforms of prostaglandin endoperoxide synthase (PGHS-1 and PGHS-2) during adipose cell differentiation
  161. Systemic Administration of Insulin-Like Growth Factor I (IGF-I) Causes Growth of the Rat Prostate
  162. Inhibition of renal ornithine decarboxylase activity fails to reduce kidney size and urinary albumin excretion in diabetic rats with manifest kidney hypertrophy
  163. Augmented effect of short-term pulsatile versus continuous insulin delivery on lipid metabolism but similar effect on whole-body glucose metabolism in obese subjects
  164. Fuel metabolism, energy expenditure, and thyroid function in growth hormone-treated obese women: A double-blind placebo-controlled study
  165. Characterization of regional and gender differences in glucocorticoid receptors and lipoprotein lipase activity in human adipose tissue.
  166. Characterization of regional and gender differences in glucocorticoid receptors and lipoprotein lipase activity in human adipose tissue
  167. Abdominal obesity is associated with insulin resistance and reduced glycogen synthase activity in skeletal muscle
  168. Lipoprotein lipase activity in muscle tissue influenced by fatness, fat distribution and insulin in obese females
  169. Increased ornithine decarboxylase activity in kidneys undergoing hypertrophy in experimental diabetes
  170. Effects of in vivo estrogen treatment on adipose tissue metabolism and nuclear estrogen receptor binding in isolated rat adipocytes
  171. Characterization of nuclear corticosteroid receptors in rat adipocytes. Regional variations and modulatory effects of hormones
  172. Regional differences in triglyceride breakdown in human adipose tissue: Effects of catecholamines, insulin, and prostaglandin E2
  173. Nuclear estradiol binding in rat adipocytes. Regional variations and regulatory influences of hormones
  174. Phosphoinositide metabolism in adipocytes from hypothyroid rats
  175. Polyamines in rat adipocytes: Their localization and their effects on the insulin receptor binding
  176. Antilipolytic Effect of Prostaglandin E2in Perifused Rat Adipocytes*